scispace - formally typeset
K

Kyan Aung

Researcher at International Medical University

Publications -  20
Citations -  290

Kyan Aung is an academic researcher from International Medical University. The author has contributed to research in topics: Randomized controlled trial & Cancer pain. The author has an hindex of 10, co-authored 18 publications receiving 246 citations.

Papers
More filters
Journal ArticleDOI

Hypertension in Malaysia: An Analysis of Trends From the National Surveys 1996 to 2011.

TL;DR: The findings suggest that the magnitude of hypertension in Malaysia needs additional attention and strengthening the screening for hypertension in primary health-care settings in the high-risk groups and frequent health promotion to the community to enhance individual awareness and commitment to healthy living would be of immense value.
Journal ArticleDOI

A Systematic Review and Meta-Analysis of Medical Students' Perspectives on the Engagement in Research

TL;DR: It was showed that engagement in research resulted in favorable reactions toward research and academic learning, and future well-designed studies using standardized research tools on how to engage students in research are recommended.
Journal ArticleDOI

Prevalence and risk factors of hypertension in myanmar: a systematic review and meta-analysis.

TL;DR: HPT was considerably prevalent in Myanmar, while the levels of awareness and controlled HPT were low, and health promotion strategy tailored to the education on modifiable risk factors and establishment of blood pressure screening in primary health care context would be of immense value.
Journal ArticleDOI

Efficacy and safety of chloroquine for treatment in patients with uncomplicated Plasmodium vivax infections in endemic countries.

TL;DR: Evidence from the trials identified for this review draw a fairly clear conclusion about the relative efficacy and safety of CQ for treating uncomplicated P. vivax malaria infection: further research in this field with well powered, randomized, non-inferiority design, using the standardized protocol is needed.
Journal ArticleDOI

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies

TL;DR: Overall, DP, artesunate-mefloquine (MAS3) and artemether-lumefentrine (AL) were equally effective for reducing the risk of recurrent parasitaemia and has the potential to become a first-line antimalarial drug.